DGAP-News: Minap .
DGAP-News: Minapharm Pharmaceuticals: RDIF and Minapharm Agree to Produce Over 40 Million Doses of the Sputnik V Vaccine in Egypt
vom 22.04.2021, 10:00 Uhr
Bild: pixabay.com
DGAP-News: Minapharm Pharmaceuticals / Key word(s): Agreement/Miscellaneous
Minapharm Pharmaceuticals: RDIF and Minapharm Agree to Produce Over 40 Million Doses of the Sputnik V Vaccine in Egypt
22.04.2021 / 10:00
RDIF and
Minapharm Agree to Produce Over 40 Million Doses of the Sputnik V Vaccine in Egypt
Moscow/Cairo/Berlin, April 22, 2021 - The Russian Direct Investment Fund (RDIF, Russia s sovereign wealth fund), Egypt s Minapharm, the regional leader in recombinant DNA technology, and its Berlin-based subsidiary ProBioGen AG announce the agreement to produce over 40 million doses per year of the world s first registered vaccine against COVID-19, Sputnik V.